Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icodextrin versus standard glucose solution for left ventricular hypertrophy in peritoneal dialysis
RBR-2mzhmj2Terminated
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of icodextrin in chronic kidney disease (CKD) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Left ventricular mass. Started Nov 2016; status: terminated.
02
Drugs
icodextrin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on RBR-2mzhmj2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2mzhmj2.